持续葡萄糖监测在新生儿及儿科重症监护病房中应用准确性的范围综述

doi:10.3761/j.issn.2096-7446.2026.08.021

摘要/Abstract

摘要：

目的了解持续葡萄糖监测在新生儿及儿科重症监护病房中应用的准确性现状。方法基于范围综述框架，系统检索Cochrane Library、Embase、PubMed、Web of Science、中国知网、万方数据库、维普数据库，检索时限为建库至2025年4月8日。结果最终纳入23篇文献，准确性评估指标主要包括平均绝对相对误差、误差网格分析、Bland-Altman分析和Pearson相关系数等。持续葡萄糖监测在新生儿及儿科重症患儿中的准确性存在较大差异，平均绝对相对误差范围为7.1%~28.3%，误差网格分析可接受区范围为89.0%~100%，Bland-Altman分析偏倚范围为-0.38~1.76 mmol/L。结论持续葡萄糖监测在新生儿及儿科重症监护病房中的应用尚处于初步阶段，临床应用需谨慎。未来需进一步构建持续葡萄糖监测规范化使用策略，以及建立针对危重患儿的专用评估标准体系。

关键词: 持续葡萄糖监测, 新生儿重症监护病房, 儿科重症监护病房, 血糖管理, 准确性评价, 范围综述

Abstract:

Objective To investigate the current status of accuracy regarding the application of continuous glu-cose monitoring（CGM） in neonatal intensive care units（NICUs） and pediatric intensive care units（PICUs）. Methods Following the scoping review framework，a systematic search was conducted in the Cochrane Library，Embase，PubMed，Web of Science，CNKI，Wanfang，and VIP databases from their inception to April 8，2025. Results A total of 23 articles were included. The primary accuracy assessment indicators included the mean absolute relative difference（MARD），error grid analysis（EGA），Bland-Altman analysis，and Pearson correlation coefficient. The accuracy of CGM in critically ill neonates and pediatric patients varied widely. MARE ranged from 7.1% to 28.3%，the clinically acceptable zone in EGA ranged from 89.0% to 100%，and the bias in Bland-Altman analysis ranged from -0.38 to 1.76 mmol/L. Conclusion The application of CGM in PICU/NICU remains in its preliminary stages，and clinical implementation requires caution. Future efforts should focus on establishing standardized protocols for CGM use and developing specialized accuracy assessment criteria for critically ill pediatric patients.

Key words: Continuous Glucose Monitoring, Neonatal Intensive Care Unit, Pediatric Intensive Care Unit, Glycemic Management, Accuracy Assessment, Scoping Review

汪依佳, 潘爱红, 王铖琛, 张哲, 李雅兰, 张梦霞, 郭秀侠. 持续葡萄糖监测在新生儿及儿科重症监护病房中应用准确性的范围综述[J]. 中华急危重症护理杂志, 2026, 7(8): 1017-1024.

WANG Yijia, PAN Aihong, WANG Chengchen, ZHANG Zhe, LI Yalan, ZHANG Mengxia, GUO Xiuxia. Accuracy of continuous glucose monitoring in neonatal and pediatric intensive care units：a scoping review[J]. Chinese Journal of Emergency and Critical Care Nursing, 2026, 7(8): 1017-1024.

图/表 4

参考文献 39

[1]	Butorac Ahel I, Lah Tomulić K, Vlašić Cicvarić I, et al. Incidence and risk factors for glucose disturbances in premature infants[J]. Medicina, 2022, 58(9):1295. doi: 10.3390/medicina58091295
[2]	Dong ML, Liu WJ, Luo YT, et al. Glycemic variability is independently associated with poor prognosis in five pediatric ICU centers in southwest China[J]. Front Nutr, 2022, 9:757982. doi: 10.3389/fnut.2022.757982
[3]	Faustino EVS, Hirshberg EL, Asaro LA, et al. Short-term adverse outcomes associated with hypoglycemia in critically ill children[J]. Crit Care Med, 2019, 47(5):706-714. doi: 10.1097/CCM.0000000000003699 pmid: 30789401
[4]	Edwards T, Alsweiler JM, Gamble GD, et al. Neurocognitive out-comes at age 2 years after neonatal hypoglycemia in a cohort of participants from the hPOD randomized trial[J]. JAMA Netw Open, 2022, 5(10):e2235989. doi: 10.1001/jamanetworkopen.2022.35989
[5]	中国医师协会儿科学分会内分泌遗传代谢学组, 中华医学会儿科学分会急救学组. 儿童及青少年特殊情况下住院高血糖管理指导建议[J]. 中华糖尿病杂志, 2020, 12(10):765-771.
	Subspecialty Group of Endocrinologic,Hereditary and Metabolic Diseases Society of Pediatrics; the Subspecialty Group of Emer-gency Medicine, the Society of Pediatrics,Chinese Medical Association. Recommendations on the management of inpatient hyperglycemia in children and adolescents under special circumstances[J]. Chin J Diabetes Mellit, 2020, 12(10):765-771.
[6]	Bao YQ, Chen L, Chen LM, et al. Chinese clinical guidelines for continuous glucose monitoring(2018 edition)[J]. Diabetes/meta-bolism Res Rev, 2019, 35(6):e3152.
[7]	Morales-Dopico L, MacLeish SA. Expanding the horizon of continuous glucose monitoring into the future of pediatric medi-cine[J]. Pediatr Res, 2024, 96(6):1464-1474. doi: 10.1038/s41390-024-03573-x
[8]	Arksey H, O’Malley L. Scoping studies:towards a methodological framework[J]. Int J Soc Res Methodol, 2005, 8(1):19-32. doi: 10.1080/1364557032000119616
[9]	Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, et al. The continuous glucose monitoring sensor in neonatal intensive care[J]. Arch Dis Child Fetal Neonatal Ed, 2005, 90(4):F307-F310.
[10]	Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Validation of the continuous glucose monitoring sensor in preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2013, 98(2):F136-F140.
[11]	Bonet J, Guiducci S, Res G, et al. Continuous glucose monitoring among infants born very preterm:evidence for accuracy in neonatal intensive care[J]. J Pediatr, 2025, 278:114416. doi: 10.1016/j.jpeds.2024.114416
[12]	Branco RG, Chavan A, Tasker RC. Pilot evaluation of continuous subcutaneous glucose monitoring in children with multi-ple organ dysfunction syndrome[J]. Pediatr Crit Care Med, 2009:1.
[13]	Bridges BC, Preissig CM, Maher KO, et al. Continuous glucose monitors prove highly accurate in critically ill children[J]. Crit Care, 2010, 14(5):R176.
[14]	Cobry EC, Pyle L, Waterman LA, et al. Accuracy of a continuous glucose monitor during pediatric type 1 diabetes inpatient admissions[J]. Diabetes Technol Ther, 2024, 26(2):119-124. doi: 10.1089/dia.2023.0375
[15]	Elder DA, Jiminez-Vega JM, Hornung LN, et al. Continuous glu-cose monitoring following pancreatectomy with islet autotransplantation in children[J]. Pediatr Transplant, 2017, 21(7):e12998. doi: 10.1111/petr.2017.21.issue-7
[16]	Giordano L, Perri A, Tiberi E, et al. The utility and safety of a continuous glucose monitoring system(CGMS) in asphyxiat-ed neonates during therapeutic hypothermia[J]. Diagnostics, 2023, 13(18):3018. doi: 10.3390/diagnostics13183018
[17]	Harris DL, Battin MR, Weston PJ, et al. Continuous glucose monitoring in newborn babies at risk of hypoglycemia[J]. J Pe-diatr, 2010, 157(2):198-202.e1.
[18]	Iglesias Platas I, Thió Lluch M, Pociello Almiñana N, et al. Continuous glucose monitoring in infants of very low birth weight[J]. Neonatology, 2009, 95(3):217-223. doi: 10.1159/000165980
[19]	Kalogeropoulou MS, Thomson L, Beardsall K. Continuous glucose monitoring during therapeutic hypothermia for hypoxic ischaemic encephalopathy:a feasibility study[J]. Arch Dis Child Fetal Neonatal Ed, 2023, 108(3):309-315. doi: 10.1136/archdischild-2022-324593
[20]	Kotzapanagiotou E, Tsotridou E, Volakli E, et al. Evaluation of continuous flash glucose monitoring in a pediatric ICU setting[J]. J Clin Monit Comput, 2020, 34(4):843-852. doi: 10.1007/s10877-019-00384-y pmid: 31482363
[21]	Marics G, Koncz L, Eitler K, et al. Effects of pH,lactate,he-matocrit and potassium level on the accuracy of continuous glucose monitoring(CGM) in pediatric intensive care unit[J]. Ital J Pediatr, 2015, 41(1):17. doi: 10.1186/s13052-015-0122-x
[22]	Park E, Kim M. Clinical use of continuous glucose monitoring in critically ill pediatric patients with diabetic ketoacidosis[J]. Diabetes Technol Ther, 2023, 25(8):529-537. doi: 10.1089/dia.2023.0012
[23]	Pott T, Jimenez-Vega J, Parker J, et al. Continuous glucose mo-nitoring in pediatric diabetic ketoacidosis[J]. J Diabetes Sci Te-chnol, 2024, 18(4):899-903.
[24]	Ramachandran B, Kanjani A, Prabhudesai S, et al. Accuracy of a real-time continuous glucose monitoring system in children with septic shock:a pilot study[J]. Indian J Crit Care Med, 2015, 19(11):642-647. doi: 10.4103/0972-5229.169331
[25]	Saw HP, Yao NW, Chiu CD, et al. The value of real-time con-tinuous glucose monitoring in premature infants of diabetic mothers[J]. PLoS One, 2017, 12(10):e0186486. doi: 10.1371/journal.pone.0186486
[26]	Segev N, Hornung LN, Tellez SE, et al. Continuous glucose mo-nitoring in the intensive care unit following total pancreatec-tomy with islet autotransplantation in children:establishing accuracy of the dexcom G6 model[J]. J Clin Med, 2021, 10(9):1893. doi: 10.3390/jcm10091893
[27]	Thomson L, Elleri D, Bond S, et al. Targeting glucose control in preterm infants:pilot studies of continuous glucose monitoring[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(4):F353-F359.
[28]	Win M, Beckett R, Thomson L, et al. Continuous glucose monitoring in the management of neonates with persistent hypoglycemia and congenital hyperinsulinism[J]. J Clin Endocrinol Metab, 2022, 107(1):e246-e253. doi: 10.1210/clinem/dgab601
[29]	刘宁, 程国强, 张鹏, 等. 实时动态血糖监测系统在低血糖高危新生儿中应用的可行性研究[J]. 中华实用儿科临床杂志, 2019, 34(1):19-23.
	Liu N, Cheng GQ, Zhang P, et al. The exploration of Guardian real-time continuous monitoring system in high-risk infants with hypoglycemia[J]. Chin J Appl Clin Pediatr, 2019, 34(1):19-23.
[30]	Piper HG, Alexander JL, Shukla A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery[J]. Pediatrics, 2006, 118(3):1176-1184. doi: 10.1542/peds.2006-0347 pmid: 16951013
[31]	Tiberi E, Cota F, Barone G, et al. Continuous glucose monitoring in preterm infants:evaluation by a modified Clarke error grid[J]. Ital J Pediatr, 2016, 42(1):29. doi: 10.1186/s13052-016-0236-9
[32]	Reiterer F, Polterauer P, Schoemaker M, et al. Significance and reliability of MARD for the accuracy of CGM systems[J]. J Diabetes Sci Technol, 2017, 11(1):59-67. doi: 10.1177/1932296816662047 pmid: 27566735
[33]	Clarke WL, Cox D, Gonder-Frederick LA, et al. Evaluating cli-nical accuracy of systems for self-monitoring of blood glucose[J]. Diabetes Care, 1987, 10(5):622-628. doi: 10.2337/diacare.10.5.622 pmid: 3677983
[34]	Parkes JL, Slatin SL, Pardo S, et al. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose[J]. Diabetes Care, 2000, 23(8):1143-1148. doi: 10.2337/diacare.23.8.1143 pmid: 10937512
[35]	Klonoff DC, Lias C, Vigersky R, et al. The surveillance error grid[J]. J Diabetes Sci Technol, 2014, 8(4):658-672. doi: 10.1177/1932296814539589 pmid: 25562886
[36]	王煜非. 解读ISO15197:2013标准[J]. 中国糖尿病杂志, 2014, 22(12):1149-1152.
	Wang YF. Interpretation of ISO15197:2013[J]. Chin J Diabe-tes, 2014, 22(12):1149-1152.
[37]	《持续葡萄糖监测临床应用专家共识2024》专家组. 持续葡萄糖监测临床应用专家共识2024[J]. 国际内分泌代谢杂志, 2024, 44(6):430-445.
	Expert Group for Expert Consensus on Clinical Application of Continuous Glucose Monitoring(2024). Expert consensus for clinical application of continuous glucose monitoring(2024)[J]. Int J Endocrinol Metab, 2024, 44(6):430-445.
[38]	Setford SJ. The impact of interfering substances on continuous glucose monitors:part 1:classification of continuous glucose monitoring devices and mechanisms of substance interference[J]. J Diabetes Sci Technol, 2025:19322968251377027.
[39]	Jensch H, Setford S, Thomé N, et al. Dynamic interference te-sting-unexpected results obtained with the Abbott libre 2 and dexcom G6 continuous glucose monitoring devices[J]. Sensors, 2025, 25(7):1985. doi: 10.3390/s25071985